Literature DB >> 16284915

The acute disposition of (R)- and (s)-methadone in brain and lung of sheep.

David J R Foster1, Richard N Upton, Andrew A Somogyi, Cliff Grant, Allison Martinez.   

Abstract

The cerebral and lung kinetics of the enantiomers of methadone were quantified using a conscious chronically instrumented sheep preparation, as these organs are the major organs governing the peak brain concentrations (and therefore effects) of methadone after ivbolus administration. Seven sheep were administered intravenous infusions of rac-methadone (30 mg over 4 min). Whole blood (R)- and (S)-methadone concentrations were measured using stereoselective HPLC. Methadone transiently increased cardiac output (CO) and mean arterial pressure, but did not alter cerebral blood flow (CBF) or cause significant respiratory depression. Using physiologically based kinetic models, cerebral kinetics were inferred from arterio-sagittal sinus concentration gradients and CBF, lung kinetics from pulmonary artery-aortic gradient and CO. Lung and cerebral kinetics were best described by a partially membrane-limited model for both enantiomers. Lung kinetics displayed clear stereoselectivity, due to the smaller apparent volume of the deep lung compartment for (R)-methadone (45 l) compared to (S)-methadone (79 l). This resulted in systemic differences in the concentrations of the enantiomers. Minimal stereoselectivity was observed in cerebral kinetics. The brain:blood equilibration of methadone was slow (half-life of 18 min) due to intermediate permeability and large apparent cerebral distribution volumes. However, the permeability term was sufficiently high that cerebral kinetics were affected by CBF. Simulations demonstrated that if CBF was doubled, the equilibration half-life of methadone with brain tissue decreased by 30%, and there was a 25% increase in the peak brain concentrations. Future studies are needed to confirm the role of cerebral blood flow alterations in the exposure of the brain to methadone, especially in the case of respiratory depression. In conclusion, pharmacokinetic modelling of methadone confirmed a large equilibration delay between brain and blood.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16284915     DOI: 10.1007/s10928-005-0056-9

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  42 in total

1.  Isolation and mapping of the first ruminant multidrug resistance genes.

Authors:  M Longley; S H Phua; T C van Stijn; A M Crawford
Journal:  Anim Genet       Date:  1999-06       Impact factor: 3.169

2.  Agreement between ultrasonic Doppler venous outflow and Kety and Schmidt estimates of cerebral blood flow.

Authors:  D J Doolette; R N Upton; C Grant
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-09       Impact factor: 2.557

3.  The metabolic fate of the optical isomers of methadone.

Authors:  C Y SUNG; E L WAY
Journal:  J Pharmacol Exp Ther       Date:  1953-11       Impact factor: 4.030

Review 4.  Mechanisms of fatal opioid overdose.

Authors:  J M White; R J Irvine
Journal:  Addiction       Date:  1999-07       Impact factor: 6.526

Review 5.  Strategies for the treatment of cancer pain in the new millennium.

Authors:  C Ripamonti; E D Dickerson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Urinary metabolites of dl-methadone in maintenance subjects.

Authors:  H R Sullivan; S L Due
Journal:  J Med Chem       Date:  1973-08       Impact factor: 7.446

7.  Accumulation of amines in the isolated perfused rabbit lung.

Authors:  M W Anderson; T C Orton; R D Pickett; T E Eling
Journal:  J Pharmacol Exp Ther       Date:  1974-05       Impact factor: 4.030

8.  Uptake and efflux of 1-alpha-acetylmethadol (LAAM) and methadone in the isolated perfused rat lung.

Authors:  D L Roerig; C A Dawson; R I Wang
Journal:  Drug Metab Dispos       Date:  1982 May-Jun       Impact factor: 3.922

9.  The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine.

Authors:  K Kristensen; C B Christensen; L L Christrup
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

10.  Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception.

Authors:  E E Codd; R P Shank; J J Schupsky; R B Raffa
Journal:  J Pharmacol Exp Ther       Date:  1995-09       Impact factor: 4.030

View more
  1 in total

1.  Blood-brain equilibration kinetics of levo-alpha-acetyl-methadol using a chronically instrumented sheep preparation.

Authors:  David J R Foster; Mette L Jensen; Richard N Upton; Andrew A Somogyi; Cliff Grant; Allison Martinez
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.